Search results for: Jorge Mestre-Ferrandiz
Filter search results
Realising the Value of Medical Research: Health and Economic Benefits
20 March 2013
…Economics Related research available on the OHE website HERG, OHE and RAND Europe. (2008) Medical research: what’s it worth? London: Office of Health Economics. Mestre-Ferrandiz, J., Mordoh, A. and Sussex, J….
Performance-Based Risk Sharing in Health Care: Current Status
17 April 2013
…for prescription medicines from Office of Health Economics Examples of other OHE research on this topic Puig-Peiró, R., Mestre-Ferrandiz, J., Sussex, J. and Towse, A. (2011) Literature review on Patient…
Benefiting Sooner from Medical Research
3 February 2015
…Europe and King’s College London, significantly advances understanding of time lags in biomedical and health research. See: Hanney, S.R., Castle-Clarke, S., Grant, J., Guthrie, S., Henshall, C., Mestre-Ferrandiz, J.,…
Medical Research: How Long Does it Take?
10 February 2015
…health research. See: Hanney, S.R., Castle-Clarke, S., Grant, J., Guthrie, S., Henshall, C., Mestre-Ferrandiz, J., Pistollato, M., Pollitt, A., Sussex, J. and Wooding, S. 2015. How long does biomedical…
OHE Publishes in the Journal of Comparative Effectiveness Research: Future Expectations of Evidence of Relative Effectiveness in Europe and Comparative Effectiveness in the USA in 2020
15 April 2015
…here. Related work: Towse A. Comparative and Relative Effectiveness: A Challenge For Health Systems, Regulators, or Pharmaceutical Companies? OHE Occasional paper 2014. Mestre-Ferrandiz, J., Deverka, P., Pistollato, M….
New publication: The current and future burden of late-onset dementia in the UK: estimates and interventions
10 May 2016
…of Future Cases of Dementia from Those Born in 2015. OHE Consulting Report. London: Office of Health Economics. Marsden, G. & Mestre-Ferrandiz, J., 2015. Dementia: the R&D Landscape. OHE Research…
Value and Cancer: Journal of Cancer Policy Special Issue
25 January 2017
…J.C., Hernandez-Villafuerte, K., Shah, K., Mestre-Ferrandiz, J., Garrison, L. and Towse, A., 2014. The Expanding Value Footprint of Oncology Treatments. Consulting Report. London: Office of Health Economics. Richards, M., 2011. Achieving…
Our Contributions to the Economics of Personalised Medicine
7 March 2018
…Elements for an Expanded Cost-Effectiveness Analysis. Value in Health, 20(2), pp.213-216. DOI | PubMed Garrison, L., Mestre-Ferrandiz, J., Zamora, B. (2016). The Value of Knowing and Knowing the Value:…
Appraising Ultra-Orphan Drugs: Is Cost-per-QALY Appropriate?
22 March 2018
…by a factor of three seem arbitrary. Click here to download the full report. For more information, contact Martina Garau. Zamora, B., Maignen, F., O’Neill, P., Mestre-Ferrandiz, J. and Garau,…